Hard NAPLEX USP 800 Practice Questions

Mastering USP Chapter <800> is essential for any pharmacist preparing for the NAPLEX, as it governs the safe handling of hazardous drugs (HDs) to protect healthcare personnel, patients, and the environment. This chapter establishes strict standards for receipt, storage, compounding, dispensing, and administration of drugs that pose risks such as carcinogenicity, teratogenicity, or organ toxicity. Given the complexity of these regulations, practicing with Hard NAPLEX USP 800 Practice Questions is one of the most effective ways to ensure you can apply these standards in clinical and operational scenarios.

Concept Explanation

USP Chapter 800 provides a comprehensive set of practice and quality standards for handling hazardous drugs (HDs) to minimize exposure to healthcare workers and the environment. This chapter applies to all healthcare personnel who handle HD preparations and all entities that store, prepare, transport, or administer HDs. According to the National Institute for Occupational Safety and Health (NIOSH), drugs are classified as hazardous if they exhibit characteristics such as carcinogenicity, developmental or reproductive toxicity, organ toxicity at low doses, or genotoxicity. For students focusing on high-stakes clinical areas, integrating this knowledge with Hard NAPLEX Oncology Therapeutics Practice Questions is vital, as many oncology agents are the primary focus of USP 800 compliance.

Key requirements of USP 800 include:

• Engineering Controls: Use of Primary Engineering Controls (C-PECs) like Biological Safety Cabinets (BSCs) or Compounding Hazardous Drug Containment Isolators (CACIs) located within Secondary Engineering Controls (C-SECs) that are externally vented and maintained under negative pressure.
• Personal Protective Equipment (PPE): Requirement for double chemotherapy-rated gloves, respiratory protection (N95 or higher) during spills, and non-permeable gowns.
• Personnel Training: Documentation of competency every 12 months (or more frequently if protocols change).
• Deactivation and Decontamination: Specific chemical processes to neutralize HD residues, typically using sodium hypochlorite or specialized oxidizing agents.

To organize your study schedule for these technical standards, using a tool like the AI MasterPlan can help you allocate enough time to memorize air exchange requirements and pressure gradients. Comprehensive NAPLEX Prep must include a deep dive into these safety protocols to ensure both exam success and workplace safety.

Solved Examples

Example 1: Pressure and Airflow Requirements
A pharmacy is designing a new room for compounding hazardous sterile preparations. According to USP 800, what are the minimum requirements for the C-SEC (buffer room)?

1. Identify the type of compounding: Sterile hazardous compounding.
2. Recall the C-SEC requirements: It must be externally vented, physically separated from other areas, and maintained at a negative pressure between $0.01$ and $0.03$ inches of water column relative to adjacent areas.
3. Determine the Air Changes Per Hour (ACPH): The room must have at least 30 ACPH.
4. Solution: The room must be externally vented, have a negative pressure of $0.01$ to $0.03$ inches of water column, and provide at least 30 ACPH.

Example 2: PPE for Administration
A nurse is preparing to administer an intact, coated tablet of a hazardous drug listed on the NIOSH List Group 1. What PPE is required per USP 800 standards?

1. Determine the risk: Administration of an intact, coated tablet involves lower risk than compounding but still requires protection.
2. Consult USP 800 standards for administration: Single chemotherapy gloves are required for administering intact HDs.
3. Check for additional requirements: If the tablet needs to be crushed or if the drug was a liquid, double gloves and a gown would be necessary.
4. Solution: One pair of chemotherapy-rated gloves is the minimum requirement for administering intact, coated tablets.

Example 3: Assessment of Risk (AoR)
A facility decides not to follow all USP 800 containment requirements for a specific drug on the NIOSH list. What conditions must be met to perform an Assessment of Risk?

1. Identify which drugs qualify: Only drugs on the NIOSH list that are not active pharmaceutical ingredients (API) being compounded, or any HD that requires manipulation beyond simple counting/packaging, may be considered for an AoR.
2. Note the exceptions: Radiopharmaceuticals and drugs in final dosage forms (like finished capsules) are common candidates.
3. Define the AoR process: The facility must document the alternative containment strategies used to protect staff.
4. Solution: An AoR can be performed for HDs that are not APIs or for which no manipulation is required. It must be reviewed every 12 months.

Practice Questions

1. A pharmacy technician is cleaning a C-PEC used for compounding hazardous sterile products. Which of the following is the correct sequence for the cleaning process?

2. A technician is compounding a hazardous sterile injection in a C-PEC. During the process, the technician accidentally punctures the outer glove. What is the immediate next step according to USP 800 standards?

3. Calculate the total number of air changes per hour (ACPH) for a hazardous compounding room that is 1,000 cubic feet, given that the supply fan delivers 500 cubic feet per minute (CFM) of HEPA-filtered air. Use the formula: $$\text{ACPH} = \frac{ \text{CFM} \times 60}{ \text{Room Volume}}$$

4. Which of the following statements regarding the storage of hazardous drugs is TRUE?
A. HDs may be stored on the floor in the negative pressure room.
B. Refrigerated HDs must be stored in a dedicated refrigerator in a negative pressure area with at least 12 ACPH.
C. Non-antineoplastic HDs can be stored with other inventory if permitted by the facility policy.
D. Sterile and non-sterile HDs must be stored in separate rooms.

5. A pharmacist is supervising the receipt of a shipment containing several cases of cyclophosphamide. The shipping container appears damaged and may be leaking. What is the minimum respiratory protection required for the staff member cleaning up this potential spill?

6. According to USP 800, how often must environmental wipe sampling for HD surface residue be performed to ensure containment?

7. A facility is performing non-sterile compounding of a hazardous drug. The C-PEC used for this must be either externally vented or redundant-HEPA filtered. If the room is a C-SCA (Containment Segregated Compounding Area), what is the minimum required ACPH?

8. When compounding hazardous drugs, when should the pharmacist or technician change their chemotherapy gloves?

9. A healthcare facility is developing an Assessment of Risk (AoR) for a NIOSH Group 3 drug (reproductive toxicity only). Which of the following must be documented in the AoR?
A. The specific dosage form.
B. The type of C-PEC used for all manipulations.
C. The name of the Designated Person overseeing the AoR.
D. All of the above.

10. Which chemical agent is most appropriate for the "deactivation" step when cleaning a surface contaminated with a hazardous drug residue?

Answers & Explanations

1. Answer: Deactivation, Decontamination, Cleaning, Disinfection.
USP 800 requires a four-step process. Deactivation (e.g., bleach) renders the compound inactive. Decontamination removes the residue. Cleaning removes dirt/microbial contamination. Disinfection (e.g., 70% IPA) is the final step for sterile compounding areas to ensure a sterile environment. This sequence is critical to prevent the spread of HD residue.

2. Answer: Transition to the anteroom, remove both pairs of gloves, wash hands, and don two new pairs of chemotherapy gloves.
Gloves must be changed immediately if torn, punctured, or contaminated. Because the hazard is present, the technician must follow the proper doffing protocol to ensure no skin contact occurs. For more on high-risk technical procedures, see Hard NAPLEX Renal Therapeutics Practice Questions which often involve complex dosing calculations in sterile environments.

3. Answer: 30 ACPH.
Using the provided formula:
$$\text{ACPH} = \frac{500 \times 60}{1,000}$$
$$\text{ACPH} = \frac{30,000}{1,000} = 30$$
This meets the USP 800 minimum requirement for a sterile HD compounding buffer room.

4. Answer: B. Refrigerated HDs must be stored in a dedicated refrigerator in a negative pressure area with at least 12 ACPH.
USP 800 specifically requires refrigerated HDs to be kept in a dedicated fridge within a negative pressure environment (like the buffer room or C-SCA) with at least 12 ACPH. HDs should never be stored on the floor.

5. Answer: A full-facepiece chemical cartridge-type respirator or a Powered Air-Purifying Respirator (PAPR).
While an N95 provides protection against particles, it does not protect against gases or vapors. For spills or cleaning up leaks of HDs, a higher level of respiratory protection is required to ensure safety from aerosolized chemicals.

6. Answer: There is no mandatory frequency, but it is recommended at least every 6 months.
While USP 800 does not mandate a specific interval for wipe sampling, it strongly recommends it at baseline and at least every 6 months to verify that containment strategies are effective.

7. Answer: 12 ACPH.
For non-sterile compounding in a C-SCA or for storage areas, the minimum requirement is 12 ACPH. This differs from the 30 ACPH required for sterile compounding buffer rooms.

8. Answer: Every 30 minutes, or sooner if torn, punctured, or contaminated.
Chemotherapy gloves have a limited breakthrough time. USP 800 mandates changing the outer glove every 30 minutes during compounding to maintain the integrity of the barrier.

9. Answer: D. All of the above.
An AoR must be comprehensive. It must identify the drug, the dosage form, the risk, and the specific alternative containment strategies (like wearing a single pair of gloves) used to mitigate that risk.

10. Answer: 2% Sodium Hypochlorite (Bleach) or other EPA-registered deactivators.
Deactivation is the first step in cleaning. Sodium hypochlorite is a common agent used to break down the chemical structure of hazardous drugs. It must often be followed by a neutralizer (like sodium thiosulfate) to prevent corrosion of stainless steel surfaces.

1. Which of the following is a requirement for the gown worn during hazardous drug compounding?

• AMust be made of cotton for breathability
• BMust close in the front
• CMust be changed every 8 hours
• DMust be disposable and shown to resist permeability by HDs

Frequently Asked Questions

What is the difference between USP 797 and USP 800?

USP 797 focuses on the sterility of the preparation to protect the patient from contamination, while USP 800 focuses on the safety of the healthcare worker and the environment when handling hazardous drugs. Facilities must comply with both chapters when compounding sterile hazardous preparations.

Can I compound hazardous drugs in a positive pressure room?

No, USP 800 strictly requires that all hazardous drug compounding be performed in a negative pressure environment to prevent the escape of hazardous vapors or particles into adjacent non-hazardous areas. Positive pressure is reserved for non-hazardous sterile compounding to keep contaminants out of the ISO-5 space.

Are all chemotherapy drugs considered hazardous under USP 800?

Most chemotherapy agents are classified as hazardous, but the official determination is based on the OSHA and NIOSH guidelines. If a drug meets one of the six criteria (carcinogenicity, teratogenicity, etc.), it is subject to USP 800 standards regardless of its therapeutic class.

Is an N95 mask sufficient for cleaning a large hazardous drug spill?

An N95 respirator only protects against airborne particles and does not provide protection against gases or vapors that may be released during a large spill. For significant spills, a full-face chemical cartridge respirator or a PAPR is required for adequate protection.

What is a Closed System Transfer Device (CSTD)?

A CSTD is a drug transfer device that mechanically prevents the escape of a drug in vapor or liquid form and the entry of environmental contaminants into the system. USP 800 mandates the use of CSTDs for the administration of antineoplastic HDs and recommends them during compounding.

How should hazardous drug waste be disposed of?

Hazardous drug waste must be segregated into appropriate containers, typically yellow bins for trace chemotherapy waste and black bins for bulk hazardous waste. Disposal must comply with all local, state, and federal regulations, such as those set by the Environmental Protection Agency (EPA).